3094 Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC)
Gettinger S, Horn L, Ramalingam S, Spigel D, Paz-Ares L, Paik P, Reck M, Reckamp K, Mazières J, Stinchcombe T, Lynch M, Brahmer J. 3094 Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC). European Journal Of Cancer 2015, 51: s631. DOI: 10.1016/s0959-8049(16)31735-x.Peer-Reviewed Original ResearchNon-small cell lung cancerAdvanced squamous non-small cell lung cancerSquamous non-small cell lung cancerCell lung cancerSafety profileLung cancerSummary of findingsPatientsCancerTrials